APOLIPOPROTEIN B - ANVISA Registration 10350840226
Access comprehensive regulatory information for APOLIPOPROTEIN B in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10350840226 and manufactured by DIASYS DIAGNOSTIC SYSTEMS GMBH & CO. The registration is held by BIOSYS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, ABBOTT IRELAND DIAGNOSTICS DIVISION, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
10350840226
25351639583201112
02220795000179
Company Information
Dates and Status
Dec 26, 2011
VIGENTE
09/18/2025 19:00:01
APOLIPOPROTEÍNA B
Apo B Turbiquest
LABTEST DIAGNOSTICA S/A
10009010459
Aug 05, 2024
APOLIPOPROTEÍNA B
FAMÍLIA DE REAGENTE, CALIBRADOR E CONTROLES Optilite® Apolipoprotein B
THE BINDING SITE GROUP LTD
81357320130
Jun 26, 2023
APOLIPOPROTEÍNA B
Apolipoprotein B
THERMO FISHER SCIENTIFIC OY
80254180418
May 19, 2022
APOLIPOPROTEÍNA B
APOBT (Tina-quant Apolipoprotein B ver.2)
ROCHE DIAGNOSTICS GMBH
10287411405
Jul 22, 2019
APOLIPOPROTEÍNA B
Alinity c Apolipoprotein B Reagent Kit
ABBOTT IRELAND DIAGNOSTICS DIVISION
80146502192
Mar 18, 2019

